Topic Archives: Thomas Garrity

May 7, 2014 / Travis Johnson, Stock Gumshoe

What’s Cabot Small-Cap Confidential’s “Stock of the Decade?”

This note about a Cabot Small-Cap Confidential teaser first ran in the Friday File in the Summer of 2013, and the stock is up about 25% since then but is now being pitched as Cabot’s “Stock of the Decade”. What follows was published on June 21, 2013 and has not been updated or revised: *** […]

June 21, 2013 / Travis Johnson, Stock Gumshoe

Cabot’s “$20 Biotech Stock to Hit $48” (Plus Some Personal Buys)

I’ve got a couple quick personal portfolio updates to share with you today, including an add-on warrant buy, but first I thought you might enjoy a quick look at a teaser ad for one of Thomas Garrity’s picks from Cabot Small-Cap Confidential — they’re promoting this pretty actively right now as a “$20 biotech stock […]

December 13, 2012 / Travis Johnson, Stock Gumshoe

Cabot’s “$15 Health Care Stock to Hit $45”

The folks at Cabot are no stranger to promises of doubles and triples — and they especially like to trot out specific pitches like this one, that a health care stock is going from $15 to $45 … and that, of course, makes us quite curious about just what stock they’re talking about. You too? […]

May 31, 2012 / Travis Johnson, Stock Gumshoe

Cabot Small-Cap’s “Next Medifast”

We are apparently in a rut with health and medical teasers this week, and I haven’t the strength to jolt us out of it just yet … plus, I haven’t covered a teaser from the Cabot folks in a while, so let’s have a look at this latest one. The newsletter being promoted is Cabot […]

April 28, 2011 / Travis Johnson, Stock Gumshoe

Cabot’s “Your Wealth in the Coming Era of Universal Connectivity”

I’ve been resisting writing about this stock that Cabot is teasing for almost a year for their Small-Cap Confidential newsletter (edited by Thomas Garrity) — I started getting very similar teaser ads from them last July, as best I can tell, and the ad has continued to roll on, with minor variations, almost constantly since […]

February 19, 2009 / Travis Johnson, Stock Gumshoe

Cabot Small-Cap Confidential

Looks for hidden small cap opportunities, claims a “limited circulation” because of generally small and less liquid investments. Formerly edited by Thomas Garrity for many years, Tyler Laundon came to Cabot in 2016 after writing for some Wyatt Research newsletters for several years.

Comments

Ronald Atlas on “Is this really the No. 1 stock pick across the entire Motley Fool universe?” / Jul 17, 6:24pm

I subscribe to Thomas Garrity at Cabot Small Cap and I must tell you it has made me a lot of money. I think he has only ...